(Image courtesy DexCom)
The DexCom G4 continuous glucose monitor (CGM) received FDA approval for use in children 2-17 years. This is long-awaited good news!
In my opinion, FDA-approval in kids will mean less resistance by insurance companies to cover it…or at least I hope. It has been an integral part of our diabetes management toolkit for almost two years now.
From the press release:
“Dexcom, Inc., (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM), announced today that it has received U.S. Food and Drug Administration (FDA) approval for its CGM device: Dexcom G4® PLATINUM (Pediatric) for use in children ages 2 to 17 years with diabetes. Already approved for adults 18 and older, the Dexcom G4 PLATINUM (Pediatric) is now the only CGM system approved for children as young as two years old.”
“We are thrilled with the FDA’s approval of our Dexcom G4 PLATINUM System in the pediatric population,” said Terrance H. Gregg, CEO of Dexcom. “Daily management is relentless, and parents can now have greater peace of mind that a child’s diabetes is under control, whether the child is at home, away at school, or participating in activities or sports. The Dexcom G4 PLATINUM provides dynamic glucose information harnessing today’s most innovative technology, so that persons with diabetes can go about their daily lives without added worry.”
You Might Also Like…
Diabetes Daily (Q and I are quoted) DexCom Approved for Use in Children with Type 1 Diabetes
More posts about the continuous glucose monitor (CGM)
My essay in Diabetes Forecast magazine: The Pros of CGM Use for Kids (and Parents)
Disclosure: I do not have a financial relationship with DexCom, we pay for our child’s CGM and related supplies, and all opinions are my own.